A Report of Claudin-19 Mutation Causing Nephrocalcinosis and End-Stage Kidney Disease from Iran.

Iran J Kidney Dis

Assistant Professor of Nephrology, Firoozgar Research Development Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Published: August 2024

Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is an autosomal recessive disorder that affect children and young adults. Mutation in gene that coding the tight junction proteins Claudin-16 and Claudin-19(CLDN19) is responsible of this rare disorder. Hypomagnesemia, hypercalciuria, kidney failure and visual impairment (in CLDN 19 gene mutation) are the most common presentations of FHHNC. Here we present a 31-year-old woman with end-stage kidney disease (ESKD) on routine hemodialysis for the past eight years and was referred to Firoozgar nephrology clinic for kidney transplantation. Her past medical history included recurrent kidney stones. Although FHHNC is a rare disease, genetic evaluation recommended in patients with ESKD and concomitant nephrocalcinosis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

end-stage kidney
8
kidney disease
8
hypomagnesemia hypercalciuria
8
kidney
5
report claudin-19
4
claudin-19 mutation
4
mutation causing
4
causing nephrocalcinosis
4
nephrocalcinosis end-stage
4
disease iran
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!